Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows

By Yahoo! Finance | Sep 19, 2024 at 12:18 PM EST

Roche Holdings AG announced positive results from the phase 3 CENTERSTONE study of Xofluza, showing a reduction in influenza transmission. Xofluza was well-tolerated with no new safety concerns identified. This data could improve health outcomes at an individual and community level.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.